{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T05:29:06Z","timestamp":1786771746177,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"DOI":"10.1007\/s11655-026-4157-1","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T05:15:45Z","timestamp":1786770945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ruanjian Sanjie Formula Affects Metastasis of Lung Cancer by Regulating miR-182-5p\/EPAS1\/EMT Axis"],"prefix":"10.1007","author":[{"given":"Guan-jin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-nan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-mei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-lin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-jing","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,15]]},"reference":[{"key":"4157_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"4157_CR2","doi-asserted-by":"publisher","first-page":"108718","DOI":"10.1016\/j.lungcan.2025.108718","volume":"207","author":"P Ciammella","year":"2025","unstructured":"Ciammella P, Iori F, Borghetti P, Galaverni M, Ali E, Tiseo M, et al. Locally advanced NSCLC: overview of real-world pattern of recurrence in durvalumab era (LEOPARD trial). Lung Cancer 2025;207:108718.","journal-title":"Lung Cancer"},{"key":"4157_CR3","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/cncr.34071","volume":"128","author":"PJ Kneuertz","year":"2022","unstructured":"Kneuertz PJ, Abdel-Rasoul M, D\u2019Souza DM, Zhao J, Merritt RE. Segmentectomy for clinical stage I non-small cell lung cancer: national benchmarks for nodal staging and outcomes by operative approach. Cancer 2022;128:1483\u20131492.","journal-title":"Cancer"},{"key":"4157_CR4","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12935-023-03133-z","volume":"23","author":"MS Sadeghi","year":"2023","unstructured":"Sadeghi MS, Lotfi M, Soltani N, Farmani E, Fernandez JHO, Akhlaghitehrani S, et al. Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review. Cancer Cell Int 2023;23:284.","journal-title":"Cancer Cell Int"},{"key":"4157_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13008-025-00170-0","volume":"20","author":"I Akhlaghipour","year":"2025","unstructured":"Akhlaghipour I, Taghehchian N, Moghbeli M. Molecular pathology of microRNA-339 during tumor progression. Cell Div 2025;20:26.","journal-title":"Cell Div"},{"key":"4157_CR6","first-page":"152","volume":"56","author":"Q Wang","year":"2015","unstructured":"Wang Q, Jiao L, Kou T, Wang S, Xu L. Influence of Chinese medicines with different effects on subcutaneous tumors generated from lung cancer cells and metastasis associated micro RNAs in nude mice. J Traditional Chinese Medicine. 2015;56:152\u2013155.","journal-title":"J Traditional Chinese Medicine."},{"key":"4157_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12575-020-00117-5","volume":"22","author":"Q Wang","year":"2020","unstructured":"Wang Q, Jiao L, Wang S, Chen P, Bi L, Zhou D, et al. Adjuvant chemotherapy with Chinese herbal medicine formulas versus placebo in patients with lung adenocarcinoma after radical surgery: a multicenter, randomized, double-blind, placebo-controlled trial. Biol Proced Online 2020;22:5.","journal-title":"Biol Proced Online"},{"key":"4157_CR8","doi-asserted-by":"publisher","first-page":"6193","DOI":"10.1111\/jcmm.14501","volume":"23","author":"W Yang","year":"2019","unstructured":"Yang W, Kang Y, Zhao Q, Bi L, Jiao L, Gu Y, et al. Herbal formula Yangyinjiedu induces lung cancer cell apoptosis via activation of early growth response 1. J Cell Mol Med 2019;23:6193\u20136202.","journal-title":"J Cell Mol Med"},{"key":"4157_CR9","doi-asserted-by":"publisher","first-page":"157591","DOI":"10.1016\/j.phymed.2025.157591","volume":"150","author":"P Tong","year":"2026","unstructured":"Tong P, Li X, Li S, Li S, Chen B, Chen D, et al. Integrated metabolomics, transcriptomics and network pharmacology analysis to reveal the mechanisms of Danggui Buxue tang in treating Alzheimer\u2019s disease. Phytomedicine 2026;150:157591.","journal-title":"Phytomedicine"},{"key":"4157_CR10","doi-asserted-by":"publisher","first-page":"7120","DOI":"10.7150\/jca.60419","volume":"12","author":"W Yang","year":"2021","unstructured":"Yang W, Yin Y, Bi L, Wang Y, Yao J, Xu L, et al. MiR-182-5p promotes the metastasis and epithelial-mesenchymal transition in non-small cell lung cancer by targeting EPAS1. J Cancer 2021;12:7120\u20137129.","journal-title":"J Cancer"},{"key":"4157_CR11","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.3390\/jcm13113354","volume":"13","author":"JA Khan","year":"2024","unstructured":"Khan JA, Albalkhi I, Garatli S, Migliore M. Recent advancements in minimally invasive surgery for early stage non-small cell lung cancer: a narrative review. J Clin Med 2024;13:3354.","journal-title":"J Clin Med"},{"key":"4157_CR12","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1101\/gad.257394.114","volume":"29","author":"FM Kouri","year":"2015","unstructured":"Kouri FM, Hurley LA, Daniel WL, Day ES, Hua Y, Hao L, et al. miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma. Genes Dev 2015;29:732\u2013745.","journal-title":"Genes Dev"},{"key":"4157_CR13","first-page":"381","volume":"28","author":"L Zhang","year":"2011","unstructured":"Zhang L, Liu T, Huang Y, Liu J. microRNA-182 inhibits the proliferation and invasion of human lung adenocarcinoma cells through its effect on human cortical actin-associated protein. Int J Mol Med 2011;28:381\u2013388.","journal-title":"Int J Mol Med"},{"key":"4157_CR14","first-page":"1248","volume":"12","author":"H Yao","year":"2019","unstructured":"Yao H, Kong F, Zhou Y. MiR-182 promotes cell proliferation, migration and invasion by targeting FoxF2 in endometrial carcinoma cells. Int J Clin Exp Pathol 2019;12:1248\u20131259.","journal-title":"Int J Clin Exp Pathol"},{"key":"4157_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s10020-021-00338-8","volume":"27","author":"C Lu","year":"2021","unstructured":"Lu C, Zhao Y, Wang J, Shi W, Dong F, Xin Y, et al. Breast cancer cell-derived extracellular vesicles transfer miR-182-5p and promote breast carcinogenesis via the CMTM7\/EGFR\/AKT axis. Mol Med 2021;27:78.","journal-title":"Mol Med"},{"key":"4157_CR16","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.3390\/cancers13092068","volume":"13","author":"I Abramovic","year":"2021","unstructured":"Abramovic I, Vrhovec B, Skara L, Vrtaric A, Nikolac Gabaj N, Kulis T, et al. MiR-182-5p and miR-375-3p have higher performance than PSA in discriminating prostate cancer from benign prostate hyperplasia. Cancers (Basel) 2021;13:2068.","journal-title":"Cancers (Basel)"},{"key":"4157_CR17","doi-asserted-by":"publisher","first-page":"e18361","DOI":"10.1111\/jcmm.18361","volume":"28","author":"X Lu","year":"2024","unstructured":"Lu X, Zhang W, Zhang J, Ren D, Zhao P, Ying Y. EPAS1, a hypoxia- and ferroptosis-related gene, promotes malignant behaviour of cervical cancer by ceRNA and super-enhancer. J Cell Mol Med 2024;28:e18361.","journal-title":"J Cell Mol Med"},{"key":"4157_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00066-020-01665-1","volume":"197","author":"Q Zhen","year":"2021","unstructured":"Zhen Q, Zhang Y, Gao L, Wang R, Chu W, Zhao X, et al. EPAS1 promotes peritoneal carcinomatosis of non-small-cell lung cancer by enhancing mesothelial-mesenchymal transition. Strahlenther Onkol 2021;197:141\u2013149.","journal-title":"Strahlenther Onkol"},{"key":"4157_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12957-018-1378-6","volume":"16","author":"J Luo","year":"2018","unstructured":"Luo J, Shi K, Yin SY, Tang RX, Chen WJ, Huang LZ, et al. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation. World J Surg Oncol 2018;16:76.","journal-title":"World J Surg Oncol"},{"key":"4157_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12943-017-0689-5","volume":"16","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Lou Y, Zhang J, Fu Q, Wei T, Sun X, et al. Hypoxia-inducible factor-2\u03b1 promotes tumor progression and has crosstalk with Wnt\/\u03b2-catenin signaling in pancreatic cancer. Mol Cancer 2017;16:119.","journal-title":"Mol Cancer"},{"key":"4157_CR21","doi-asserted-by":"publisher","first-page":"803766","DOI":"10.3389\/fcell.2022.803766","volume":"10","author":"D Feng","year":"2022","unstructured":"Feng D, Shi X, Xiong Q, Zhang F, Li D, Wei W, et al. A ferroptosis-related gene prognostic index associated with biochemical recurrence and radiation resistance for patients with prostate cancer undergoing radical radiotherapy. Front Cell Dev Biol 2022;10:803766.","journal-title":"Front Cell Dev Biol"},{"key":"4157_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol 2019;20:69\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4157_CR23","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bbcan.2017.06.006","volume":"1868","author":"S Goossens","year":"2017","unstructured":"Goossens S, Vandamme N, Van Vlierberghe P, Berx G. EMT transcription factors in cancer development re-evaluated: beyond EMT and MET. Biochim Biophys Acta Rev Cancer 2017; 1868: 584\u2013591.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"4157_CR24","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue T, Weinberg RA. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol 2017;14:611\u2013629.","journal-title":"Nat Rev Clin Oncol"},{"key":"4157_CR25","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/1759-7714.12270","volume":"6","author":"J Liu","year":"2015","unstructured":"Liu J, Wang S, Zhang Y, Fan HT, Lin HS. Traditional Chinese medicine and cancer: history, present situation, and development. Thorac Cancer 2015;6:561\u2013569.","journal-title":"Thorac Cancer"},{"key":"4157_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12943-025-02245-6","volume":"24","author":"Z Xi","year":"2025","unstructured":"Xi Z, Dai R, Ze Y, Jiang X, Liu M, Xu H. Traditional Chinese medicine in lung cancer treatment. Mol Cancer 2025;24:57.","journal-title":"Mol Cancer"},{"key":"4157_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11010-017-3171-1","volume":"441","author":"K Yamagata","year":"2018","unstructured":"Yamagata K, Izawa Y, Onodera D, Tagami M. Chlorogenic acid regulates apoptosis and stem cell marker-related gene expression in A549 human lung cancer cells. Mol Cell Biochem 2018;441:9\u201319.","journal-title":"Mol Cell Biochem"},{"key":"4157_CR28","doi-asserted-by":"publisher","first-page":"110673","DOI":"10.1016\/j.biopha.2020.110673","volume":"131","author":"L Wang","year":"2020","unstructured":"Wang L, Du H, Chen P. Chlorogenic acid inhibits the proliferation of human lung cancer A549 cell lines by targeting annexin A2 in vitro and in vivo. Biomed Pharmacother 2020;131:110673.","journal-title":"Biomed Pharmacother"},{"key":"4157_CR29","doi-asserted-by":"publisher","first-page":"e0139298","DOI":"10.1371\/journal.pone.0139298","volume":"10","author":"J Bao","year":"2015","unstructured":"Bao J, Huang B, Zou L, Chen S, Zhang C, Zhang Y, et al. Hormetic effect of berberine attenuates the anticancer activity of chemotherapeutic agents. PLoS One 2015;10:e0139298.","journal-title":"PLoS One"},{"key":"4157_CR30","doi-asserted-by":"publisher","first-page":"1617604","DOI":"10.3389\/fimmu.2025.1617604","volume":"16","author":"L Hao","year":"2025","unstructured":"Hao L, Li S, Deng J, Hu X. Zuojin Capsule improves T cell exhaustion and tumor immune microenvironment of hepatocellular carcinoma through the mTOR-eIF4E\/p70S6K-CDK1 pathway. Front Immunol 2025;16:1617604.","journal-title":"Front Immunol"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-4157-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-026-4157-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-4157-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T05:15:46Z","timestamp":1786770946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-026-4157-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,15]]},"references-count":30,"alternative-id":["4157"],"URL":"https:\/\/doi.org\/10.1007\/s11655-026-4157-1","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,15]]},"assertion":[{"value":"26 January 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no conflict of interests. BI Ling serves on the Youth Editorial Board of\n                      Chinese Journal of Integrative Medicine\n                      . The paper was handled by the other editor and has undergone rigorous peer review process. BI Ling was not involved in the journal\u2019s review of or decisions related to this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}